Rituximab: A Targeted Approach With Limitations in Myasthenia Gravis
Medindia,
Highlights: Rituximab's mechanism targets B cells in myasthenia gravis Efficacy shown in acetylcholine receptor antibody-positive…
Highlights: Rituximab's mechanism targets B cells in myasthenia gravis Efficacy shown in acetylcholine receptor antibody-positive…
Myasthenia gravis (MG) is a rare, acquired autoimmune disorder of the neuromuscular junction, characterized by fatigable muscle…